Periodic Benefit-Risk Evaluation Report: A European Union Regulatory Perspective Peter ArlettRodrigo PostigoAlmath Spooner Leading Article 31 October 2014 Pages: 309 - 315
The US FDA Draft Guidance for Developing Abuse-Deterrent Opioid Analgesics: 2014 and Beyond Edward M. SellersMegan J. ShramKerri A. Schoedel Leading Article 08 October 2014 Pages: 317 - 327
Drugs in Clinical Development for Duchenne Muscular Dystrophy: Summary and Table Adis Profile Summary 25 November 2014 Pages: 329 - 331